Aprea Therapeutics Inc
APRE
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.8M
Close$
$2.23
193% upside
Current Fair Value
193% upsideUndervalued by 193% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.80 Million |
|---|---|
| Enterprise Value | $-40,669,192.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.93 |
| Beta | 1.48 |
| Outstanding Shares | 7,687,961 |
Return
| Return on Equity | -27.92% |
|---|---|
| Return on Assets | -24.85% |
| Return on Invested Capital | -29.04% |
Valuation & Multiples
| P/E Ratio | -0.57 |
|---|---|
| PEG | 3.5 |
| Price to Sales | - |
| Price to Book Ratio | 0.15 |
| Enterprise Value to Revenue | -334.87 |
| Enterprise Value to EBIT | 3.27 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
$253,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 34.32%▲ 7.72% |
|---|---|
| Total Invested | $1.71M▲ 18.39% |
| Investors Holding | 220% |
ESG Score
No data